Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect: 2014-2025

Historic Exchange Rate Effect for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to -$41,000.

  • Amphastar Pharmaceuticals' Exchange Rate Effect rose 34.92% to -$41,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $208,000, marking a year-over-year increase of 149.88%. This contributed to the annual value of -$190,000 for FY2024, which is 32.62% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Exchange Rate Effect stood at -$41,000, which was down 128.87% from $142,000 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $142,000 during Q2 2025, with a 5-year trough of -$238,000 in Q4 2023.
  • In the last 3 years, Amphastar Pharmaceuticals' Exchange Rate Effect had a median value of -$22,000 in 2023 and averaged -$23,000.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Exchange Rate Effect plummeted by 1,352.63% in 2023 and then soared by 847.37% in 2025.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Exchange Rate Effect stood at -$48,000 in 2021, then surged by 139.58% to $19,000 in 2022, then crashed by 1,352.63% to -$238,000 in 2023, then spiked by 95.38% to -$11,000 in 2024, then skyrocketed by 34.92% to -$41,000 in 2025.
  • Its last three reported values are -$41,000 in Q3 2025, $142,000 for Q2 2025, and $118,000 during Q1 2025.